FDA OKs first new ADHD drug in more than a decade for children

Southwest Life

FDA OKs first new ADHD drug in more than a decade for children

Qelbree is not a stimulant or a controlled substance
Bottles for different dosages of the drug Qelbree. On Friday, April 2, 2021, the U.S. Food and Drug Administration approved the medication for treating attention deficit hyperactivity disorder in children ages 6 to 17.

FDA OKs first new ADHD drug in more than a decade for children

Bottles for different dosages of the drug Qelbree. On Friday, April 2, 2021, the U.S. Food and Drug Administration approved the medication for treating attention deficit hyperactivity disorder in children ages 6 to 17.
Listen
Loading the English audio player...
Escuchar en Español:
Loading the Español audio player...
click here to add your event
Area Events